IMPRIAZ Trademark

Trademark Overview

On Tuesday, November 23, 2021, a trademark application was filed for IMPRIAZ with the United States Patent and Trademark Office. The USPTO has given the IMPRIAZ trademark a serial number of 97139679. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, June 13, 2024. This trademark is owned by ACORDA THERAPEUTICS, INC.. The IMPRIAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system
impriaz

General Information

Serial Number97139679
Word MarkIMPRIAZ
Filing DateTuesday, November 23, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACORDA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPearl River, NY 10965
Party NameACORDA THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502

Trademark Events

Event DateEvent Description
Friday, November 26, 2021NEW APPLICATION ENTERED
Monday, November 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 28, 2022ASSIGNED TO EXAMINER
Thursday, June 30, 2022NON-FINAL ACTION WRITTEN
Thursday, June 30, 2022NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2023FINAL REFUSAL WRITTEN
Monday, February 6, 2023FINAL REFUSAL E-MAILED
Monday, February 6, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 1, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, September 16, 2023ASSIGNED TO LIE
Saturday, September 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU EXTENSION 1 FILED
Thursday, June 13, 2024SOU EXTENSION 1 GRANTED

Related Keywords

impriaz pharmaceutical disorders conditions nervous system diseases used products namely biological